References
- Al-Holou WN, O'Lynnger TM, Pandey AS, Gemmete JJ, Thompson BG, Muraszko KM, et al. Natural history and imaging prevalence of cavernous malformations in children and young adults. J Neurosurg Pediatr 2012;9:198-205. https://doi.org/10.3171/2011.11.PEDS11390
- Kivelev J, Niemelä M, Hernesniemi J. Characteristics of cavernomas of the brain and spine. J Clin Neurosci 2012;19:643-8. https://doi.org/10.1016/j.jocn.2011.08.024
- Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol 2007;6:237-44. https://doi.org/10.1016/S1474-4422(07)70053-4
- D'Angelo R, Scimone C, Calabro M, Schettino C, Fratta M, Sidoti A. Identification of a novel CCM2 gene mutation in an Italian family with multiple cerebral cavernous malformations and epilepsy: a causative mutation? Gene 2013;519:202-7. https://doi.org/10.1016/j.gene.2012.09.045
- Reddy S, Gorin MB, McCannel TA, Tsui I, Straatsma BR. Novel KRIT1/CCM1 mutation in a patient with retinal cavernous hemangioma and cerebral cavernous malformation. Graefes Arch Clin Exp Ophthalmol 2010;248:1359-61. https://doi.org/10.1007/s00417-010-1329-6
- Wang X, Liu XW, Lee N, Liu QJ, Li WN, Han T, et al. Features of a Chinese family with cerebral cavernous malformation induced by a novel CCM1 gene mutation. Chin Med J (Engl) 2013;126:3427-32.
- Kupfs H. Uber heredofamiliare Angiomatose des Gehirens und der Retina, ihre Beziehungen zueinander und zur Angiomatose der Haut. Z Gesamte Neurol Psychiatr 1928;113:651-86. https://doi.org/10.1007/BF02884519
- Denier C, Labauge P, Brunereau L, Cave-Riant F, Marchelli F, Arnoult M, et al. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol 2004;55:213-20. https://doi.org/10.1002/ana.10804
- Gault J, Shenkar R, Recksiek P, Awad IA. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 2005;36:872-4. https://doi.org/10.1161/01.STR.0000157586.20479.fd
- Wustehube J, Bartol A, Liebler SS, Brütsch R, Zhu Y, Felbor U, et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A 2010;107:12640-5. https://doi.org/10.1073/pnas.1000132107
- Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 2013;498:492-6. https://doi.org/10.1038/nature12207
- Denier C, Labauge P, Bergametti F, Marchelli F, Riant F, Arnoult M, et al. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 2006;60:550-6. https://doi.org/10.1002/ana.20947
- Kivelev J, Niemela M, Hernesniemi J. Treatment strategies in cavernomas of the brain and spine. J Clin Neurosci 2012;19:491-7. https://doi.org/10.1016/j.jocn.2011.08.015
- Lee ST, Choi KW, Yeo HT, Kim JW, Ki CS, Cho YD. Identification of an Arg35X mutation in the PDCD10 gene in a patient with cerebral and multiple spinal cavernous malformations. J Neurol Sci 2008;267:177-81. https://doi.org/10.1016/j.jns.2007.10.018
- Lee YW, Lee ST, Cha JG, Park JH, Jeon BR, Lee YK, et al. A novel KRIT1 gene mutation in a patient with cerebral and multiple spinal cavernous malformations. Ann Clin Lab Sci 2010;40:290-4.
Cited by
- Cerebral Glioblastoma Mimicking a Cavernous Malformation: A Case Report and Literature Review vol.3, pp.1, 2016, https://doi.org/10.18679/cn11-6030_r.2017.005